Larimar Therapeutics, Inc.

10-Q Quarter ended 2026-06-30 Aug 4, 2026 8-K Results of operations (earnings release); Other events Aug 4, 2026 8-K Other events Jun 29, 2026 8-K Shareholder vote results May 19, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Other events May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Results of operations (earnings release) Mar 19, 2026 8-K Other events Mar 9, 2026 8-K Entered a material agreement Feb 27, 2026 8-K Other events Feb 24, 2026 8-K Unregistered sale of equity; Amended charter or bylaws Jan 22, 2026 8-K Results of operations (earnings release); Other events Jan 12, 2026 8-K Unregistered sale of equity; Amended charter or bylaws Dec 17, 2025 8-K Other events Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Other events Oct 14, 2025 8-K Other events Sep 29, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Other events Aug 14, 2025 8-K Entered a material agreement Jul 31, 2025 8-K Results of operations (earnings release) Jul 29, 2025 8-K Other events Jun 23, 2025 8-K Other events Jun 23, 2025 8-K Shareholder vote results May 13, 2025 8-K Other events May 5, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Results of operations (earnings release) Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Results of operations (earnings release); Other events Mar 24, 2025 8-K Director or officer change Jan 27, 2025 8-K Other events Jan 10, 2025 8-K Other events Dec 16, 2024 8-K Other events Nov 18, 2024 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Results of operations (earnings release); Other events Oct 30, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Other events Aug 7, 2024 8-K Other events Jun 10, 2024